A股煤炭板块短线拉升，陕西黑猫直线涨停，恒源煤电、郑州煤电、山西焦化、淮北矿业、宝泰隆等个股跟涨。

China’s National Medical Products Administration approved Genzyme Corporation’s Class 1 innovative drug rilzabrutinib tablets (trade name Sailizhi) for adults with persistent or chronic primary immune thrombocytopenia (ITP) who had inadequate response or intolerance to corticosteroids, IVIG or other prior therapies. The approval establishes a new treatment option for this patient population in China.

加拿大央行行长麦克勒姆：央行对高通胀的容忍度是有限的。